BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khomiak A, Brunner M, Kordes M, Lindblad S, Miksch RC, Öhlund D, Regel I. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers (Basel) 2020;12:E3234. [PMID: 33147766 DOI: 10.3390/cancers12113234] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Kjaergaard AD, Chen IM, Johansen AZ, Nordestgaard BG, Bojesen SE, Johansen JS. Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer. Cancers (Basel) 2021;13:4599. [PMID: 34572824 DOI: 10.3390/cancers13184599] [Reference Citation Analysis]
2 Borgmästars E, Lundberg E, Öhlund D, Nyström H, Franklin O, Lundin C, Jonsson P, Sund M. Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples. Cancers (Basel) 2021;13:5321. [PMID: 34771485 DOI: 10.3390/cancers13215321] [Reference Citation Analysis]
3 Hu X, Chen W. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. World J Clin Cases 2021; 9(19): 4998-5006 [PMID: 34307550 DOI: 10.12998/wjcc.v9.i19.4998] [Reference Citation Analysis]
4 Tonini V, Zanni M. Pancreatic cancer in 2021: What you need to know to win. World J Gastroenterol 2021; 27(35): 5851-5889 [PMID: 34629806 DOI: 10.3748/wjg.v27.i35.5851] [Reference Citation Analysis]
5 Kalthoff H. How open is the therapeutic horizon for pancreatic cancer patients? Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00204-6. [PMID: 34789410 DOI: 10.1016/j.hbpd.2021.11.005] [Reference Citation Analysis]
6 Passardi A, Rapposelli IG, Scarpi E, Sullo FG, Bartolini G, Neri E, Ghigi G, Tontini L, Ercolani G, Monti M, Ruscelli S, Matteucci L, Valgiusti M, Frassineti GL, Romeo A. Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies. Biomolecules 2021;11:1200. [PMID: 34439866 DOI: 10.3390/biom11081200] [Reference Citation Analysis]
7 Rajesh S, Cox MJ, Runau F. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach . World J Gastroenterol 2021; 27(31): 5171-5180 [PMID: 34497442 DOI: 10.3748/wjg.v27.i31.5171] [Reference Citation Analysis]
8 Li B, Shen S, You S, Zhang G, Gao S, Shi X, Wang H, Yin X, Xu X, Guo S, Jin G. Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma. BMC Cancer 2021;21:612. [PMID: 34034684 DOI: 10.1186/s12885-021-08380-9] [Reference Citation Analysis]
9 Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] [Reference Citation Analysis]
10 Orsi G, Di Marco M, Cavaliere A, Niger M, Bozzarelli S, Giordano G, Noventa S, Rapposelli IG, Garajova I, Tortora G, Rodriquenz MG, Bittoni A, Penzo E, De Lorenzo S, Peretti U, Paratore C, Bernardini I, Mosconi S, Spallanzani A, Macchini M, Tamburini E, Bencardino K, Giommoni E, Scartozzi M, Forti L, Valente MM, Militello AM, Cascinu S, Milella M, Reni M. Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey. ESMO Open 2021;6:100238. [PMID: 34392104 DOI: 10.1016/j.esmoop.2021.100238] [Reference Citation Analysis]
11 Auwercx J, Rybarczyk P, Kischel P, Dhennin-Duthille I, Chatelain D, Sevestre H, Van Seuningen I, Ouadid-Ahidouch H, Jonckheere N, Gautier M. Mg2+ Transporters in Digestive Cancers. Nutrients 2021;13:210. [PMID: 33450887 DOI: 10.3390/nu13010210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ge P, Luo Y, Chen H, Liu J, Guo H, Xu C, Qu J, Zhang G, Chen H. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Front Oncol 2021;11:667427. [PMID: 34707986 DOI: 10.3389/fonc.2021.667427] [Reference Citation Analysis]
13 Zhang Y, Yang J, Wang X, Li X. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Sci Rep 2021;11:20441. [PMID: 34650124 DOI: 10.1038/s41598-021-99544-x] [Reference Citation Analysis]